Physician profile
Peter J Shupper
NPI 1578902284
$2,069.45
in general payments reported to CMS, 2019-2025
13 companies · $66.50 in 2025
The $66.50 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $333 · 2021: $14.92 · 2022: $138 · 2023: $901 · 2024: $209 · 2025: $66.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690 · Travel and Lodging: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.28 |
| Travel and Lodging | $486.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $946.00 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $421.12 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $158.52 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Medtronic USA, INC. | $134.24 | 2019 | |
| Abbott Laboratories | $80.24 | 2019 | |
| Nalu Medical, INC. | $71.40 | 2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $57.04 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.36 | 2019 | |
| Medtronic, INC. | $51.47 | 2023-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $32.77 | 2020 | |
| Biodelivery Sciences International, INC. | $25.09 | 2019 | |
| Nevro Corp. | $19.03 | 2023 | Senza |
| Vertos Medical, INC. | $16.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shupper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.